Biotechnology News

October 3, 2012

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--NuMedii, Inc. today announced a strategic alliance with Aptalis Pharma to discover and develop new methods of treatment for certain gastrointestinal disorders and cystic fibrosis.

October 3, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, announced that it will release its financial results for the third quarter of 2012 before the market opens on Wednesday, October 24,...

October 3, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Pharmaceutical portfolio management teams have increasingly turned to pediatric extension strategies to extend their brands’ lifecycles and net a high rate of return, according to benchmarking study...

October 3, 2012

IRVINE, Calif.--(BUSINESS WIRE)--BioMedGPS' projects EU Bone Replacement Market to reach over $264MM by 2016, according to SmartTRAK BI Hub

October 3, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem will participate in cancer stem cell panel at BIO Investor Forum on October 9, 2012, at 10:30am PT.

October 3, 2012

BALTIMORE--(BUSINESS WIRE)--BioMarker Strategies names Executive Chairman to commercialize SnapPath live tumor cell testing system to predict cancer patient response to targeted drug therapies

October 3, 2012

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (NASDAQ: PURE), the creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced it has initiated testing of SDC-based formulas in direct food applications to determine...

October 3, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--The US military continues to show strong interest in researching Oxycyte as a potential therapeutic for a variety of military casualties. The latest CRADA will look at using Oxycyte for wounds.

October 3, 2012

SAN DIEGO--(BUSINESS WIRE)--A four-year prospective study shows that therapy guided by bioTheranostics’ CancerTYPE ID® molecular test improves survival in cancer of unknown primary patients.

October 3, 2012

MORRISTOWN, N.J.--(BUSINESS WIRE)--Durata Therapeutics CEO Paul Edick will discuss dalbavancin, in Phase 3 trials for the treatment of ABSSSI, at the BIO Investor Forum on September 10.

October 3, 2012

SEATTLE--(BUSINESS WIRE)--NanoString announced the appointment of James A. Johnson as the company’s new Chief Financial Officer (CFO). Wayne Burns was appointed Senior Vice President Finance & Administration.

October 3, 2012

DUBLIN & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles is working to improve understanding of drug-induced blood pressure responses and help our customers improve trial participant safety, manage risk, and improve efficiency.

October 3, 2012

DUBLIN--(BUSINESS WIRE)--Covidien plc (NYSE: COV) will report fourth-quarter results on November 9, 2012, before trading begins. The Company will hold a conference call for investors at 8:30 a.m. ET. The call can be accessed in the following ways...

October 3, 2012

AUSTIN, Texas--(BUSINESS WIRE)--Leading innovation solutions company Emergent Technologies, Inc. appoints new President Kris Looney and new Executive Vice President and Director of Life Sciences Brian Windsor due to company growth.

October 3, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Looks To China for Stem Cell Research

October 3, 2012

NEW YORK & PARIS--(BUSINESS WIRE)--Bionest Partners hosted a panel at the recent Burrill Personalized Medicine Conference

October 3, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical peripheral nerve stimulation study for chronic migraine published online by Cephalalgia shows a significant reduction in pain, headache days and disability.

October 3, 2012

PARIS & NEW YORK--(BUSINESS WIRE)--Sanofi and Bristol-Myers Squibb Announce Restructuring of Alliance Agreement

October 2, 2012

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced a public offering of shares of its common stock. This offering, which is subject to market and other conditions, is being made pursuant to its existing shelf...

October 2, 2012

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (NYSE MKT: IMUC) today announced that Peter Ho, PhD, Director of Business Development, will present a company overview at 2:00 pm ET and participate in a panel...

October 2, 2012

FARMINGTON, Conn.--(BUSINESS WIRE)--Advancements in Robotic Surgery at Shawnee Mission Medical Center - 2 robotic web programs.

October 2, 2012

CARY, N.C.--(BUSINESS WIRE)--ISR's provides insight into trends impacting the global central lab market, a market size assessment, the use of strategic geographies, and an evaluation of central lab service providers' quality.

October 2, 2012

RICHMOND, Va.--(BUSINESS WIRE)--AIBioTech is quickly gaining ground in the niche market of custom synthesis of small molecules, including molecules which contain stable isotopes of particular atoms. The products of these syntheses are routinely...

October 2, 2012

ANN ARBOR, Mich.--(BUSINESS WIRE)--Ann Arbor-based Online Tech is bringing its industry-leading knowledge of secure hosting services to SecureWorld Expo Detroit, an education and training conference held Wednesday and Thursday at the Ford Motor...

October 2, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: Cellectis (Alternext: ALCLS), the French genome engineering specialist, announces in the Journal of Biological Chemistry, one of the most respected scientific journals in the world, the publication of a...

October 2, 2012

BOSTON--(BUSINESS WIRE)--Governor Patrick joined ARGO Medical Technologies and the Massachusetts Life Sciences Center to announce the Israeli-founded exoskeleton technology leader chose Massachusetts as its US headquarters.

October 2, 2012

WARSAW, Ind.--(BUSINESS WIRE)--Biomet, Inc. (“Biomet”) today announced the early tender results of the previously announced cash tender offer (the “Tender Offer”) for any and all of its 10% Senior Notes due 2017 (CUSIP Nos. 090613AC4; 550785AA7;...

October 2, 2012

WARSAW, Ind.--(BUSINESS WIRE)--Biomet, Inc. today announced the completion of its previously announced offering of $825 million aggregate principal amount of senior notes due 2020 (the “Additional Senior Notes”), at an issue price of 105.000%...

October 2, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC: Parkinson’s Costs Expected to Rise

October 2, 2012

SAN MATEO, Calif.--(BUSINESS WIRE)--CCGroup is proud to be the first company to release a free grouper of medical condition episodes to the public.

October 2, 2012

MADISON, Wis.--(BUSINESS WIRE)--Promega announces the introduction of a novel cytotoxicity assay that can be used on cell cultures for up to 72 hours...

October 2, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--New research by Cutting Edge Information aims to help call center managers assess their operations, increase efficiency and generate a bigger impact.

October 2, 2012

WESTCHESTER, N.Y.--(BUSINESS WIRE)--As part of Healthy Skin Month October, 2012, ENT and Allergy Associates, LLP (ENTA), the largest ear, nose, throat, allergy and audiology practice in the tri-state area, is once again helping to generate...

October 2, 2012

SAN BRUNO, Calif.--(BUSINESS WIRE)--A San Francisco Bay Area Clinical Research Organization (CRO) named PRC Clinical provides project management, clinical monitoring, data management, safety and site payment services joins BayBio.

October 2, 2012

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--TYRX, Inc. has been named to the FierceMedicalDevices “Fierce 15” list, designating it as one of the leading medical device and diagnostic companies of 2012.

October 2, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems has been selected as a member of the Fierce 15 MedicalDevices award for its game-changing diagnostic technology, capable of direct detection of any immunological or molecular target.

October 2, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced that the company has been named one of FierceMedicalDevices’ Fierce 15 most promising privately held medical device...

October 2, 2012

MENLO PARK, Calif.--(BUSINESS WIRE)--CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced that the company has been named to the FierceMedicalDevices “Fierce 15” list, designating...

October 2, 2012

LYON & GRENOBLE, France--(BUSINESS WIRE)--Aguettant, a French pharmaceutical company, and PX’Therapeutics, Contract Manufacturing Organization dedicated to the development of recombinant proteins, join forces to boost their activities

October 2, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--StatLink® Systems, a Memphis-based process management company, has announced the purchase of AccuRead Endoscopy, a California-based capsule endoscopy reading company.

October 2, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that the multiple myeloma drug market will experience significant growth, increasing...

October 2, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that, nine months after commercial availability in the US, Regeneron’s Eylea captures 13...

October 2, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--EndoGastric Solutions Completes Enrollment for Clinical Trial that compares transoral fundoplication to medical therapy such as PPIs for the treatment of GERD.

October 2, 2012

HAZELWOOD, Mo.--(BUSINESS WIRE)--Mallinckrodt, the Pharmaceuticals business of Covidien (NYSE: COV), today announced that it has completed its acquisition of CNS Therapeutics, Inc. for approximately $100 million. CNS is a privately held specialty...

October 2, 2012

SOMERSET, N.J.--(BUSINESS WIRE)--Catalent Pharma Solutions, a world industry leader in drug development and advanced delivery technologies, today announced the establishment of a global alliance with PAREXEL International Corporation to help...

October 2, 2012

BOSTON--(BUSINESS WIRE)--Third Rock Ventures, LLC, a venture capital firm focused on building life sciences companies, today announced that Felix W. Frueh, Ph.D., has joined Third Rock as an entrepreneur-in-residence (EIR). As an EIR, Dr. Frueh...

October 2, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Drug companies employ an average of 28 full-time equivalents (FTEs) around the world to oversee their investigator-initiated trial (IIT) operations, according to study by Cutting Edge Information.

October 2, 2012

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Metagenics Announces Free Educational Webinar October 24 on the Role of Medical Foods in Managing Chronic Diseases